
### [NCIT:C4437](http://purl.obolibrary.org/obo/NCIT_C4437)
**Label:** Liver Sarcoma

**Subclasses:** [NCIT:C5833](http://purl.obolibrary.org/obo/NCIT_C5833) (Liver Extraskeletal Osteosarcoma), [NCIT:C5756](http://purl.obolibrary.org/obo/NCIT_C5756) (Liver Leiomyosarcoma), [NCIT:C5834](http://purl.obolibrary.org/obo/NCIT_C5834) (Liver Rhabdomyosarcoma), [NCIT:C5832](http://purl.obolibrary.org/obo/NCIT_C5832) (Liver Fibrosarcoma), [NCIT:C96844](http://purl.obolibrary.org/obo/NCIT_C96844) (Liver Kaposi Sarcoma), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [UBERON:0002107](http://purl.obolibrary.org/obo/UBERON_0002107) (liver) 52.94%
- [NCIT:C43614](http://purl.obolibrary.org/obo/NCIT_C43614) (Hepatobiliary Tissue) 52.94%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3892](http://purl.obolibrary.org/obo/NCIT_C3892) (Mu Heavy Chain Disease))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38850](http://purl.obolibrary.org/obo/NCIT_C38850) (Phosphatidylinositol Signaling System Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38834](http://purl.obolibrary.org/obo/NCIT_C38834) (MAPK Signaling Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38829](http://purl.obolibrary.org/obo/NCIT_C38829) (Focal Adhesion Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38828](http://purl.obolibrary.org/obo/NCIT_C38828) (Inositol Phosphate Metabolism Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3880](http://purl.obolibrary.org/obo/NCIT_C3880) (Eyelid Nevus))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38784](http://purl.obolibrary.org/obo/NCIT_C38784) (Apoptosis Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38762](http://purl.obolibrary.org/obo/NCIT_C38762) (Thyroid Gland Mucoepidermoid Carcinoma))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3876](http://purl.obolibrary.org/obo/NCIT_C3876) (Gastric Leiomyoma))) 38.30%


